Störungen der weiblichen Gonaden

Abramov Y, Fatum M, Abrahamov D, Schenker JG (2001) Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 75:1228–1230PubMedCrossRefGoogle Scholar

Arbeitsgemeinschaft Diabetes und Schwangerschaft der Deutschen Diabetesgesellschaft (DDG), Arbeitsgemeinschaft für maternofetale Medizin (AGMFM) der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und Deutsche Gesellschaft für Perinatale Medizin (2001) Empfehlungen zu Diagnostik und Therapie des Gestationsdiabetes 2001Google Scholar

Barbieri RL, Hornstein MD (1999) Assisted reproductionin vitro ferlilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropinreleasing hormone analogues. Endocr Rev 20: 249–252PubMedCrossRefGoogle Scholar

Conway GS (2000) Premature ovarian failure. Br Med Bulletin 56: 643–649CrossRefGoogle Scholar

Cosman F, Lindsay R (1999) Selective estrogen receptor modulators: Clinical spectrum. Endocr Rev 20:418–434PubMedCrossRefGoogle Scholar

Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 18:774–800PubMedCrossRefGoogle Scholar

Eismann JA (1999) Genetics of osteoporosis. Endocr Rev 20:788–804CrossRefGoogle Scholar

Ellis MH, Beyth Y (1999) Abnormal vaginal bleeding in adolescence as the presenting symptom of a bleeding diathesis. J Pediatr Adolesc Gynecol 12:127–131PubMedCrossRefGoogle Scholar

Favus MJ (1999) Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar

Filicori M, Flamigni C (1996) The ovary: Regulation, dysfunction and treatment. International Congress Series 1106. Elsevier, AmsterdamGoogle Scholar

Filicori M, Santoro N, Merriam G, Crowley WF Jr (1986) Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocinol Metab62:1139Google Scholar

Hammond MG (1984) Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction. Fertil Steril 42:499PubMedGoogle Scholar

Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HPG (1994) Evaluation der klimakterischen Beschwerden. [Menopause Rating Scale (MRS)]. Zentralbl Gynäkol 116:16PubMedGoogle Scholar

Henderson VW (2000) Hormone therapy and the brain — A clinical perspective on the role of estrogen. The Parthenon Publishing Group, New York LondonGoogle Scholar

Hinney B, Henze C, Wuttke W (1995) Regulation of luteal function by luteinizing hormone and prolactin at different times of the luteal phase. Eur J Endocrinol 133:701PubMedCrossRefGoogle Scholar

Hinney B, Henze C, Kuhn W, Wuttke W (1996) The corpus luteum insufficiency: A multifactorial disease. J Clin Endocrinol Metab 81:565–570PubMedCrossRefGoogle Scholar

Kemmeren JM, Algra A, Grobbee DE (2001) Third generation oral contraceptives and risk of venous thrombosis: metaanalysis. BMJ 323:131–134PubMedCrossRefGoogle Scholar

Leyendecker G, Wildt L (1983) Induction of ovulation with chronic intermittent (pulsatile) administration on Gn-RH in women with hypothalamic amenorrhea. J Reprod Fertil 69:397PubMedCrossRefGoogle Scholar

Ludwig M, Bauer O, Diedrich K (1997) Überblick über das ovarielle Überstimulationssyndrom: ein reproduktionsmedizinischiatrogenes Krankheitsbild mit internistischer Konsequenz. Wien Med Wochenschr 147:516–524PubMedGoogle Scholar

Ludwig M, Felberbaum RE, Devroey P, Albano C, Riethmuller-Winzen H, Schuler A, Engel W, Diedrich K (2000) Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 264:29–32PubMedCrossRefGoogle Scholar

Lunenfeld B, Insler V, Glezerman M (1992) Diagnosis and treatment of functional intertility. Blackwell, LondonGoogle Scholar

Marchbanks PA, McDonald JA, Wilson HG et al. (2002) Oral contraceptives and the risk of breast cancer. N Engl J Med 346: 2078–2079CrossRefGoogle Scholar

Nicolaides KH (2005) First-trimester screening for chromosomal abnormalities. Semin Perinatol. 29:190–4PubMedCrossRefGoogle Scholar

Penzias AS (2002) Luteal phase support. Fertil Steril 77:318–323PubMedCrossRefGoogle Scholar

Pinkerton JV, Santen R (1999) Alternatives to the use of estrogen in postmenopausal women. Endocr Rev 20:308–320PubMedCrossRefGoogle Scholar

Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC (1999) The insulinrelated ovarian regulatory system in health and disease. Endocr Rev 20:535–582PubMedCrossRefGoogle Scholar

Prior JC (1998) Perimenopause: The complex endocinology of the menopausal transition. Endocr Rev 19:397–428PubMedCrossRefGoogle Scholar

Schenker JG (1999) Clinical aspects of ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 85:13–20PubMedCrossRefGoogle Scholar

Speroff L, Glass RH, Kase NG (1999) Clinical Gynecologic endo-crinology and infertility, 6th edn. Lippincott Williams & Wilkins, BaltimoreGoogle Scholar

Tartaryn IV, Meldrum DR, Lu KH, Frumar AM, Judd HL (1979) LH, FSH and skin temperature during the menopausal hot flash. J Clin Endocrinol Metab 49:152–154CrossRefGoogle Scholar

Wu O, Robertson L, Langhorne P et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thromb Haemost 94:17–25PubMedGoogle Scholar

Wuttke W, Pitzel L, Seidlová-Wuttke D, Hinney B (2001) LH pulses and the corpus luteum: The luteal phase deficiency (LPD). Vitamins and Hormones 63:131–157PubMedCrossRefGoogle Scholar